A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

NCT01732822 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

13885

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Artery Disease

Interventions

DRUG: Ticagrelor
DRUG: Clopidogrel

Sponsor

AstraZeneca